A citation-based method for searching scientific literature

Hailin Chen, Tengteng Yu, Liang Lin, Lijie Xing, Shih-Feng Cho, Kenneth Wen, Kimberly Aardalen, Adwait Oka, Joni Lam, Mike Daley, Haihui Lu, Nikhil Munshi, Kenneth C Anderson, Yu-Tzu Tai. Blood Cancer J 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



CAR-T design: Elements and their synergistic function.
Jayapriya Jayaraman, Michael P Mellody, Andrew J Hou, Ruchi P Desai, Audrey W Fung, An Huynh Thuy Pham, Yvonne Y Chen, Weian Zhao. EBioMedicine 2020
69
100

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
Aaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, Olga Goloubeva, Dan T Vogl, Simon F Lacey, Ashraf Z Badros, Alfred Garfall, Brendan Weiss, Jeffrey Finklestein,[...]. Nat Med 2015
545
100

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
G Dranoff, E Jaffee, A Lazenby, P Golumbek, H Levitsky, K Brose, V Jackson, H Hamada, D Pardoll, R C Mulligan. Proc Natl Acad Sci U S A 1993
100

Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockade.
William H D Hallett, Weiqing Jing, William R Drobyski, Bryon D Johnson. Biol Blood Marrow Transplant 2011
130
100

Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens.
Selma Bekri, Reunet Rodney-Sandy, Diana Gruenstein, Anna Mei, Bjarne Bogen, John Castle, Daniel Levey, Hearn Jay Cho. J Immunother Cancer 2022
2
100

Teclistamab in Relapsed or Refractory Multiple Myeloma.
Philippe Moreau, Alfred L Garfall, Niels W C J van de Donk, Hareth Nahi, Jesús F San-Miguel, Albert Oriol, Ajay K Nooka, Thomas Martin, Laura Rosinol, Ajai Chari,[...]. N Engl J Med 2022
13
100

Harnessing natural killer cells for the treatment of multiple myeloma.
Joseph A Clara, Richard W Childs. Semin Oncol 2022
2
100

Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients.
Lior Carmon, Irit Avivi, Riva Kovjazin, Tsila Zuckerman, Lillian Dray, Moshe E Gatt, Reuven Or, Michael Y Shapira. Br J Haematol 2015
42
100

Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study.
Katy J McCann, Rosemary Godeseth, Lindsey Chudley, Ann Mander, Gianfranco Di Genova, Paul Lloyd-Evans, Jonathan P Kerr, Vladimir B Malykh, Matthew W Jenner, Kim H Orchard,[...]. Cancer Immunol Immunother 2015
23
100

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith,[...]. Immunity 2016
539
100

Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T cell Function against Multiple Myeloma Is Enhanced in the Presence of Lenalidomide.
Melissa Works, Neha Soni, Collin Hauskins, Catherine Sierra, Alex Baturevych, Jon C Jones, Wendy Curtis, Patrick Carlson, Timothy G Johnstone, David Kugler,[...]. Mol Cancer Ther 2019
45
100

Allogeneic Stem Cell Transplantation in Multiple Myeloma.
Christine Greil, Monika Engelhardt, Jürgen Finke, Ralph Wäsch. Cancers (Basel) 2021
2
100


RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.
Michael Schmitt, Anita Schmitt, Markus T Rojewski, Jinfei Chen, Krzysztof Giannopoulos, Fei Fei, Yingzhe Yu, Marlies Götz, Marta Heyduk, Gerd Ritter,[...]. Blood 2008
163
100

Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.
Matteo C Da Vià, Oliver Dietrich, Marietta Truger, Panagiota Arampatzi, Johannes Duell, Anke Heidemeier, Xiang Zhou, Sophia Danhof, Sabrina Kraus, Manik Chatterjee,[...]. Nat Med 2021
53
100

Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.
Xiuli Wang, Miriam Walter, Ryan Urak, Lihong Weng, Christian Huynh, Laura Lim, ChingLam W Wong, Wen-Chung Chang, Sandra H Thomas, James F Sanchez,[...]. Clin Cancer Res 2018
97
100

'Off-the-shelf' allogeneic CAR T cells: development and challenges.
S Depil, P Duchateau, S A Grupp, G Mufti, L Poirot. Nat Rev Drug Discov 2020
321
100


Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma.
Eugenia Zah, Eunwoo Nam, Vinya Bhuvan, Uyen Tran, Brenda Y Ji, Stanley B Gosliner, Xiuli Wang, Christine E Brown, Yvonne Y Chen. Nat Commun 2020
76
100

An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission.
Luca Biavati, Carol Ann Huff, Anna Ferguson, Amy Sidorski, M Amanda Stevens, Lakshmi Rudraraju, Cristina Zucchinetti, Syed Abbas Ali, Philip Imus, Christian B Gocke,[...]. Clin Cancer Res 2021
5
100

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Jesus G Berdeja, Deepu Madduri, Saad Z Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D Cohen, A Keith Stewart, Parameswaran Hari, Myo Htut, Alexander Lesokhin,[...]. Lancet 2021
216
100

Allogeneic stem cell transplantation for multiple myeloma: is there a future?
B Dhakal, D H Vesole, P N Hari. Bone Marrow Transplant 2016
38
100

A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma.
Di Wang, Jue Wang, Guang Hu, Wen Wang, Yi Xiao, Haodong Cai, Lijun Jiang, Li Meng, Yongkun Yang, Xiaoxi Zhou,[...]. Blood 2021
49
100

Myeloid-derived suppressor cells in hematological malignancies: friends or foes.
Meng Lv, Ke Wang, Xiao-Jun Huang. J Hematol Oncol 2019
38
100

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains.
Carlos A Ramos, Barbara Savoldo, Vicky Torrano, Brandon Ballard, Huimin Zhang, Olga Dakhova, Enli Liu, George Carrum, Rammurti T Kamble, Adrian P Gee,[...]. J Clin Invest 2016
208
100

A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.
Muzaffar H Qazilbash, Neeraj Y Saini, Soung-Chul Cha, Zhe Wang, Edward A Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal S Rao,[...]. Blood 2022
2
100

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma.
Alfred L Garfall, Marcela V Maus, Wei-Ting Hwang, Simon F Lacey, Yolanda D Mahnke, J Joseph Melenhorst, Zhaohui Zheng, Dan T Vogl, Adam D Cohen, Brendan M Weiss,[...]. N Engl J Med 2015
409
100

Cellular Immunotherapy for Multiple Myeloma.
Jacalyn Rosenblatt, David Avigan. Cancer J 2019
9
100

Next-generation cell therapies: the emerging role of CAR-NK cells.
Rafet Basar, May Daher, Katayoun Rezvani. Blood Adv 2020
52
100

Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.
Ramesh B Batchu, Amberly M Moreno, Susann M Szmania, Grant Bennett, Guilio C Spagnoli, Selvarangan Ponnazhagan, Bart Barlogie, Guido Tricot, Frits van Rhee. Cancer Res 2005
50
100

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions.
Luis Gerardo Rodríguez-Lobato, Maya Ganzetti, Carlos Fernández de Larrea, Michael Hudecek, Hermann Einsele, Sophia Danhof. Front Oncol 2020
41
100

Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine Release.
Christina L Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong, Matthew J Bernett, Umesh S Muchhal, Gregory L Moore, Jennitte Stevens, Ryan Case, Joshua T Pearson, Siyuan Liu,[...]. Clin Cancer Res 2019
66
100

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.
Adrienne H Long, Waleed M Haso, Jack F Shern, Kelsey M Wanhainen, Meera Murgai, Maria Ingaramo, Jillian P Smith, Alec J Walker, M Eric Kohler, Vikas R Venkateshwara,[...]. Nat Med 2015
884
100

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.
Gerald P Linette, Edward A Stadtmauer, Marcela V Maus, Aaron P Rapoport, Bruce L Levine, Lyndsey Emery, Leslie Litzky, Adam Bagg, Beatriz M Carreno, Patrick J Cimino,[...]. Blood 2013
715
100

Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life.
Christine Greil, Monika Engelhardt, Gabriele Ihorst, Katja Schoeller, Hartmut Bertz, Reinhard Marks, Robert Zeiser, Justus Duyster, Hermann Einsele, Jürgen Finke,[...]. Haematologica 2019
42
100

Drug resistance in multiple myeloma.
Pawel Robak, Izabela Drozdz, Janusz Szemraj, Tadeusz Robak. Cancer Treat Rev 2018
140
100

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.
Sarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, Terence J Purdon, Dayenne G van Leeuwen, Dylan J Drakes, Mei Song, Matthew M Miele, Zhuoning Li, Pei Wang,[...]. Nat Biotechnol 2018
379
100

T-cell tolerance: central and peripheral.
Yan Xing, Kristin A Hogquist. Cold Spring Harb Perspect Biol 2012
236
100

Immune Modulation in Hematologic Malignancies.
Madhav V Dhodapkar, Kavita M Dhodapkar. Semin Oncol 2015
16
100

Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1.
Mariko Ishibashi, Hideto Tamura, Mika Sunakawa, Asaka Kondo-Onodera, Namiko Okuyama, Yasuko Hamada, Keiichi Moriya, Inhak Choi, Koji Tamada, Koiti Inokuchi. Cancer Immunol Res 2016
72
100

Advances in immunotherapy in multiple myeloma.
Leora Boussi, Ruben Niesvizky. Curr Opin Oncol 2017
13
100

Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector.
Eric L Smith, Mette Staehr, Reed Masakayan, Ishan J Tatake, Terence J Purdon, Xiuyan Wang, Pei Wang, Hong Liu, Yiyang Xu, Sarah C Garrett-Thomson,[...]. Mol Ther 2018
61
100

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma.
Carlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, Khong Y Ng, Yunxin Chen, William D Godfrey, Terence J Purdon, Vladimir Ponomarev, Hans-Guido Wendel, Renier J Brentjens,[...]. Blood Cancer Discov 2020
65
100


Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Jacalyn Rosenblatt, Baldev Vasir, Lynne Uhl, Simona Blotta, Claire Macnamara, Poorvi Somaiya, Zekui Wu, Robin Joyce, James D Levine, Dilani Dombagoda,[...]. Blood 2011
154
100

Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study.
Saad Z Usmani, Alfred L Garfall, Niels W C J van de Donk, Hareth Nahi, Jesus F San-Miguel, Albert Oriol, Laura Rosinol, Ajai Chari, Manisha Bhutani, Lionel Karlin,[...]. Lancet 2021
54
100

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma.
Tobias Bexte, Jamal Alzubi, Lisa Marie Reindl, Philipp Wendel, Ralf Schubert, Emilia Salzmann-Manrique, Ivana von Metzler, Toni Cathomen, Evelyn Ullrich. Oncoimmunology 2022
4
100

How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma.
Adam D Cohen, Noopur Raje, Jessica A Fowler, Khalid Mezzi, Emma C Scott, Madhav V Dhodapkar. Clin Cancer Res 2020
44
100

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
Alexander M Lesokhin, Stephen M Ansell, Philippe Armand, Emma C Scott, Ahmad Halwani, Martin Gutierrez, Michael M Millenson, Adam D Cohen, Stephen J Schuster, Daniel Lebovic,[...]. J Clin Oncol 2016
687
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.